Panagora Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
AC
RA
Panagora Asset Management's CPRX Position: Q3 2021 in Review
Panagora Asset Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2021, closing a stake of 1,780 shares — an estimated $10K sold.
Panagora Asset Management first reported a position in CPRX in Q1 2015 and held it in 17 quarters. The position peaked at $2.31M in Q3 2018. 144 funds tracked by Wall St. Rank hold CPRX as of Q3 2021.
- Panagora Asset Management reported no remaining Catalyst Pharmaceutical position as of Q3 2021 after selling out during the quarter.
- Panagora Asset Management sold 1,780 Catalyst Pharmaceutical shares in Q3 2021, an estimated $10K.
- Panagora Asset Management first reported a position in Catalyst Pharmaceutical in Q1 2015 and held it in 17 quarters.
- Panagora Asset Management's Catalyst Pharmaceutical position peaked at $2.31M in Q3 2018.
- 144 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2021.
Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.